COMMUNIQUÉS West-GlobeNewswire
      -   
  
BioSig & Streamex Appoint Parcl Co-Founders Trevor Bacon and Kellan Grenier as Strategic Advisors
09/06/2025 -   
  
New medial stabilized insert for Smith+Nephew’s LEGION™ Total Knee System designed to improve kinematics, stability and procedural versatility
09/06/2025 -   
  
Medicovestor, Inc. and Sanyou Biopharmaceuticals Forge Strategic Partnership to Develop First-in-Class Chemoimmunotherapy Antibody-Drug Conjugates
09/06/2025 -   
  
Micron Biomedical Names Health Education and Empowerment Advocate, Dr. Jayne Morgan, to Board of Advisors
09/06/2025 -   
  
Longeveron® to Participate in the H.C. Wainwright 6th Annual Neuro Perspectives Hybrid Conference
09/06/2025 -   
  
Circuit Clinical Solutions Inc. [“Circuit Clinical”] and Lightship Inc. [“Lightship”] Announce Strategic Merger to Accelerate Scale and Expanded Access in Clinical Research
09/06/2025 -   
  
Ambio Life Sciences Launches World's First Clinical Ibogaine Program for Patients With Neurodegenerative Conditions
09/06/2025 -   
  
MD Anderson and HealthEx Announce Collaboration to Develop New Platform to Give Patients Direct Control of Data Access
09/06/2025 -   
  
Tevogen Expands Headquarters Amid Growth of AI and Generics & Biosimilars Initiatives
09/06/2025 -   
  
AVITA Medical Highlights Largest Real-World Analysis Demonstrating Reduced Hospital Stay with RECELL
09/06/2025 -   
  
Journey Medical Corporation Announces Emrosi™ Featured on “The Balancing Act” Airing on Lifetime TV
09/06/2025 -   
  
FibroBiologics Appoints Jason D. Davis, CPA, as Chief Financial Officer
09/06/2025 -   
  
Maravai LifeSciences Appoints Bernd Brust as Chief Executive Officer and Member of its Board of Directors
09/06/2025 -   
  
Microbot Medical Continues to Strengthen Commercial Capabilities in Preparation for the anticipated Q3 2025 Launch of its LIBERTY® Endovascular Robotic System
09/06/2025 -   
  
Catheter Precision, Inc. Secures VIVO Purchase Order From Sahlgrenska University Hospital
09/06/2025 -   
  
De nouvelles analyses confirment les avantages à long terme de la quadrithérapie DARZALEX® (daratumumab) par voie sous-cutanée chez les patients atteints d’un myélome multiple nouvellement diagnostiqué
09/06/2025 -   
  
OPKO Health’s ModeX Therapeutics Announces Formation of Scientific Advisory Board with Leaders at the Forefront of Immunology and Oncology Drug Development
09/06/2025 -   
  
LifeMD to Participate in Two Investor Conferences During June
09/06/2025 -   
  
Beacon Therapeutics Strengthens Leadership Team with the Appointment of Dr. Daniel Chung as Chief Medical Officer
09/06/2025 
Pages